MENU
+Compare
ARRY
Stock ticker: NASDAQ
AS OF
Oct 14, 04:59 PM (EDT)
Price
$9.07
Change
+$0.28 (+3.19%)
Capitalization
1.34B

ARRY Array Technologies Forecast, Technical & Fundamental Analysis

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects... Show more

Industry: #Biotechnology
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARRY with price predictions
Oct 13, 2025

ARRY in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 01, 2025

ARRY broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In of the 35 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 48 cases where ARRY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 25, 2025. You may want to consider a long position or call options on ARRY as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARRY just turned positive on October 01, 2025. Looking at past instances where ARRY's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ARRY advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 133 cases where ARRY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.432) is normal, around the industry mean (7.272). P/E Ratio (56.911) is within average values for comparable stocks, (110.987). Projected Growth (PEG Ratio) (0.675) is also within normal values, averaging (1.085). ARRY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (1.142) is also within normal values, averaging (17.964).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

View a ticker or compare two or three
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARRY is expected to report earnings to fall 23.48% to 19 cents per share on November 06

Array Technologies ARRY Stock Earnings Reports
Q3'25
Est.
$0.19
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.04
The last earnings report on August 07 showed earnings per share of 25 cents, beating the estimate of 18 cents. With 2.87M shares outstanding, the current market capitalization sits at 1.34B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical drugs

Industry AlternativePowerGeneration

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3901 Midway Place NE
Phone
+1 505 881-7567
Employees
1028
Web
https://www.arraytechinc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAIRX10.19N/A
N/A
Victory Trivalent Intl Fd-Core Eq R6
OALGX23.36N/A
N/A
Optimum Large Cap Growth A
BTSMX24.28N/A
N/A
Boston Trust SMID Cap
FMDRX32.92N/A
N/A
Franklin Mutual Global Discovery R6
PGKCX28.66N/A
N/A
PGIM Jennison Technology C

ARRY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been loosely correlated with NXT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ARRY jumps, then NXT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
+0.57%
NXT - ARRY
61%
Loosely correlated
+5.02%
SHLS - ARRY
57%
Loosely correlated
+5.59%
RUN - ARRY
56%
Loosely correlated
+12.61%
FSLR - ARRY
54%
Loosely correlated
+0.11%
AXON - ARRY
53%
Loosely correlated
+0.99%
More

Groups containing ARRY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
+0.57%
Alternative Power Generation
industry (32 stocks)
21%
Poorly correlated
+1.49%
Utilities
industry (223 stocks)
11%
Poorly correlated
+0.51%